Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

• Status: Completed
• Trial end date: 2010-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether 2 weeks of treatment with AZD1446 compared to placebo improves ADHD symptoms and is well tolerated.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca

Criteria

Inclusion Criteria:

• A confirmed diagnosis of ADHD

• Patient understands and is willing to comply with all study requirements

• Adults between the ages of 18-65 inclusive

Exclusion Criteria:

• Current psychiatric disorder other than ADHD

• Previous randomization into this study

• Women with a positive pregnancy test